Skip to main content
    B

    Bio-Techne Corp (TECH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $72.79
    -0.01 (-0.01%)

    Market Cap: $11.44B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Bio-Techne Corp (TECH) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Bio-Techne are BridgeBio Pharma (BBIO), TG Therapeutics (TGTX) and Krystal Biotech (KRYS). Bio-Techne trades at 39.6x earnings, against a median of 40.4x for the 5 of these companies with a P/E. By market cap, Bio-Techne ranks 2nd of the 13 companies on this page; BridgeBio Pharma (BBIO) is the largest at $15.25B.

    Peer Comparison

    TECH's ROIC of 7.7% is above the peer median of -33.0%, and its revenue growth of 4.6% is below the median of 35.6%. It yields 0.44%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Bio-Techne (TECH)$11.44B39.6x9.3x14.0%7.7%4.6%0.44%
    BridgeBio Pharma Inc (BBIO)$15.25BN/A16.0x-59.8%-33.0%192.6%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Krystal Biotech Inc (KRYS)$9.05B40.4x18.8x47.9%N/A30.2%0.00%
    Summit Therapeutics PLC (SMMT)$11.32BN/AN/A0.0%N/A-100.0%0.00%
    Twist Bioscience Corp (TWST)$7.40BN/A14.3x-28.3%N/A27.9%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Praxis Precision Medicines Inc (PRAX)$9.17BN/AN/A0.0%N/A1349.0%0.00%
    Spyre Therapeutics Inc. (SYRE)$9.88BN/AN/A0.0%N/A0.0%0.00%
    Protagonist Therapeutics Inc (PTGX)$8.55B27.7x15.8x62.0%N/A5724.0%0.00%
    Halozyme Therapeutics Inc (HALO)$11.43B17.8x6.1x26.9%15.8%39.2%0.00%
    Cytokinetics Inc (CYTK)$7.82BN/A65.3x0.0%-66.0%2357.0%0.00%
    Cogent Biosciences Inc (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    Peer median$9.11B40.4x15.0x0.0%-33.0%35.6%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Bio-Techne, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    BridgeBio Pharma Inc (BBIO)
    BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases.
    BBIO competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Krystal Biotech Inc (KRYS)
    Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United...
    KRYS competitors
    Summit Therapeutics PLC (SMMT)
    Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America...
    SMMT competitors
    Twist Bioscience Corp (TWST)
    Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products.
    TWST competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Praxis Precision Medicines Inc (PRAX)
    Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal...
    PRAX competitors
    Spyre Therapeutics Inc. (SYRE)
    Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by...
    SYRE competitors
    Protagonist Therapeutics Inc (PTGX)
    Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical...
    PTGX competitors
    Halozyme Therapeutics Inc (HALO)
    Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally.
    HALO competitors
    Cytokinetics Inc (CYTK)
    Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering...
    CYTK competitors
    Cogent Biosciences Inc (COGT)
    Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases.
    COGT competitors

    Frequently Asked Questions About TECH

    Who are Bio-Techne's main competitors?

    The companies most similar to Bio-Techne include BridgeBio Pharma (BBIO), TG Therapeutics (TGTX), Krystal Biotech (KRYS), Summit Therapeutics (SMMT) and Twist Bioscience (TWST), listed from the closest match.

    Who is Bio-Techne's biggest competitor?

    BridgeBio Pharma (BBIO) is both the largest of the similar companies at $15.25B and the closest match by business profile, size, sector and industry.

    How does TECH stock compare with its competitors?

    TECH's P/E is 39.6x against a peer median of 40.4x; its P/S is 9.3x against a peer median of 15.0x; its net margin is 14.0% against a peer median of 0.0%.

    Which of Bio-Techne's competitors pays a higher dividend?

    Bio-Techne has a forward dividend yield of 0.44%. None of the similar companies with available yields has a higher forward dividend yield.

    Is Bio-Techne bigger than its competitors?

    No. Bio-Techne is 2nd by market cap among the 13 companies on this page; the largest is BridgeBio Pharma (BBIO) at $15.25B.